SCHEMBL7617985

SCHEMBL7617985

O=C(O)CCCCc1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.68
RXFP1 Q9HBX9 1/20 0.68
HDAC3 O15379 1/20 0.61
MAPK1 P28482 1/20 0.61
ADRA1A P35348 1/20 0.61
HDAC4 P56524 1/20 0.61
SLC6A3 Q01959 1/20 0.61
HDAC1 Q13547 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC2 Q92769 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61
FFAR1 O14842 4/20 0.54
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2131203 0.98 MAPT (0.66) MAPTRXFP1HDAC3MAPK1ADRA1A
Bromide SCHEMBL9650134 0.93 HDAC1 (0.67) MAPTRXFP1HDAC3MAPK1ADRA1A
Heptane SCHEMBL11228269 0.90 MAPT (0.59) MAPTRXFP1HDAC3MAPK1ADRA1A
Bromide SCHEMBL9875660 0.84 MAPT (0.60) MAPTRXFP1HDAC3MAPK1ADRA1A
5-Phenylvaleric Acid SCHEMBL503601 0.83 MAPT (0.96) MAPTRXFP1HDAC3MAPK1ADRA1A
SCHEMBL7065645 0.83 MAPT (0.79) MAPTRXFP1HDAC3MAPK1ADRA1A
Bromide SCHEMBL993390 0.83 MAPT (0.63) MAPTRXFP1HDAC3MAPK1ADRA1A
SCHEMBL2553009 0.81 MAPT (1.00) MAPTRXFP1HDAC3MAPK1ADRA1A
SCHEMBL2555645 0.81 MAPT (1.00) MAPTRXFP1HDAC3MAPK1ADRA1A
SCHEMBL1008757 0.81 MAPT (1.00) MAPTRXFP1HDAC3MAPK1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1228031-A2 OMEGA CHAIN MODIFIED 15-HYDROXYEICOSATETRAENOIC ACID DERIVATIVES AND METHODS OF THEIR USE FOR THE TREATMENT OF DRY EYE Alcon Universal, Ltd. (CH) 2002-08-07 EP disclosed
WO-2001034546-A2 OMEGA CHAIN MODIFIED 15-HYDROXYEICOSATETRAENOIC ACID DERIVATIVES AND METHODS OF THEIR USE FOR THE TREATMENT OF DRY EYE ALCON UNIVERSAL LTD. (CH) 2001-05-17 WO disclosed